Referring to our patient, we believe this COVID-19-associated hemostasis abnormality (CAHA) started in the heart rather than the lung then progressed to involve both pulmonary arteries before being detected. A very much less reported scenario, suggesting that the local damage that happens after COVID infection, predisposes the affected individuals into a lifelong increased risk for thromboembolism.